BiotechTube
Home/Ochre Bio/Quin Wills
QW

Quin Wills

Founder & CEO

Ochre Bio

Therapeutic Areas

Chronic Liver DiseaseLiver FibrosisCirrhosisMASH/MASLD

Ochre Bio Pipeline

DrugIndicationPhase
OB-220Significant FibrosisPreclinical
Undisclosed Metabolic ProgramCirrhosis (F4 MASH)Preclinical
Undisclosed Multiple Mechanism ProgramSignificant FibrosisDiscovery
Undisclosed Regeneration ProgramCirrhosisDiscovery

Leadership Team at Ochre Bio

EF
Eliot Forster, PhD
Board Chair
JC
Jack Castle
Chief Business Officer
SB
Sarah Batey
Chief Operating Officer
CU
Chinwe Ukomadu, MD, PhD
Board Observer
View full Ochre Bio profile